Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
10/2005
10/19/2005CN1223346C Pharmaceutical and nutritional compositions containing essential fatty acids and homocysteine-lowering agents
10/19/2005CN1223340C Electrospun pharmaceutical compositions
10/19/2005CN1223338C Cetirizine hydrochloride gel
10/18/2005US6956059 use in relief of rheumatoid arthritis, rheumatoid spondylitis, osteroarthritis, gouty arthritis and other arthritic conditions, inflamed joints, eczema and other inflammatory skin conditions, inflammatory eye conditions, aids, hiv
10/18/2005US6956050 Imidazole compounds as anti-inflammatory and analgesic agents
10/18/2005US6956045 Anticancer agents; antiallergens; immunology diseases; antiinflamamtory agents
10/18/2005US6956043 Pharmaceutical compositions comprising 33-epi-chloro-33-desoxy-ascomycin solid dispersions
10/18/2005US6956042 N-aryl diazaspiracyclic compounds and methods of preparation and use thereof
10/18/2005US6956041 Protein kinase inhibitors
10/18/2005US6956037 Benzamide derivatives for the treatment of diseases mediated by cytokines
10/18/2005US6956033 3,4-dihydroisoquinoline derivative compound and a pharmaceutical agent comprising it as active ingredient
10/18/2005US6955883 Life sciences business systems and methods
10/18/2005US6955815 Combinations for the treatment of inflammatory disorders
10/18/2005US6955810 Method for the treatment of inflammatory disorders
10/18/2005CA2340138C 2-oxo-imidazolidine-4-carboxylic acid hydroxamide compounds that inhibit matrix metalloproteinases
10/18/2005CA2152507C Novel combination of benzoquinazoline antifolates and protecting agents
10/18/2005CA2148928C Pharmacologically active pyridine derivatives and processes for the preparation thereof
10/18/2005CA2104399C Antiviral activity and resolution of 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane
10/13/2005WO2005095416A1 Process for producing flavone c glycoside derivatives
10/13/2005WO2005095412A1 Antiallergic agent
10/13/2005WO2005095381A1 Dipeptidyl peptidase inhibitors
10/13/2005WO2005094889A1 Remedy or preventive for arthritis
10/13/2005WO2005094886A1 Methods of inducing differentiation of regulatory t-cells and proliferating the same with gpi anchor protein agonist and medicinal composition therefor
10/13/2005WO2005094881A1 Antibody drug
10/13/2005WO2005094880A1 Method for treating autoimmune diseases with antibodies
10/13/2005WO2005094851A1 Water-soluble fraction extracted from animal organ, method of producing the same, reverse transcription inhibitor, reverse transcriptase inhibitor, viral growth inhibitor and medicinal compositions
10/13/2005WO2005094811A1 Pharmaceutical product containing tranilast
10/13/2005WO2005094805A1 Imine derivative and amide derivative
10/13/2005WO2004064717A3 Cop 1 for treatment of inflammatory bowel diseases
10/13/2005WO2003068954A8 Microorganism for genetic therapeutic treatment of proliferative diseases
10/13/2005US20050228170 B7-like molecules and uses thereof
10/13/2005US20050228055 Substituted nitrobenzene derivatives as pharmaceutical and other uses athereof
10/13/2005US20050228042 Statin-like compounds
10/13/2005US20050228036 3-(arylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors
10/13/2005US20050228018 Chemical compounds
10/13/2005US20050228005 Protein kinase inhibitors and uses thereof
10/13/2005US20050227997 Selective inhibition of aggrecanase in osteoarthritis treatment
10/13/2005US20050227991 Containing a piperazine ring, e.g., N'-(4-{4-[5-(1,2-dithiolan-3-yl)pentanoyl]-1-piperazinyl)phenyl)-2-thiophenecarboximidamide and intermediates for preparing them; useful for inhibiting NO synthase and regenerating antioxidants
10/13/2005US20050227988 compounds capable of inhibiting, modulating and/or regulating signal transduction of both receptor-type and non-receptor type tyrosine kinases; gliomas, meningomas, cancers, Hodgkin's disease, retinal vascularization; core structure that comprises a benzazocine moiety
10/13/2005US20050227986 Vanilloid receptor ligands and their use in treatments
10/13/2005US20050227979 E.g., 1-[4-(1-Isopropyl-piperidin-4-yloxy)-benzyl]-piperidine and 1-[4-(1-Isopropyl-piperidin-4-yloxy)-benzyl]-azepane; these compounds modulate the activity of the histamine receptor, specifically the H3 receptor, without the inherent problems associated with the presence of an imidazolyl moiety
10/13/2005US20050227967 Treatment of T-helper cell type 2-mediated immune diseases by retinoid antagonists
10/13/2005US20050227957 Therapy for oxidation stresses; complex of drug and enzyme mimetics; lipophilic cation moiety covalently bonded to glutathione peroxidase mimetic moiety is selected from the group consisting of: benzisoselenazolones, diaryl diselenides and diaryl selenides
10/13/2005US20050227951 Verification of translation
10/13/2005US20050227948 Hif hydroxylase inhibitors
10/13/2005US20050227354 Using fibronectin nutrient broth to propagate cytotoxic lymphocyte with enhanced interleukin-2 receptor expression profiles; immunotherapy; antitumor agents
10/13/2005US20050227280 Proteases
10/13/2005US20050227277 Apoptosis proteins
10/13/2005US20050227249 Polymorphisms in the human MDR-1 gene and their use in diagnostic and therapeutic applications
10/13/2005US20050227233 Method for diagnosing and treating schizophrenia
10/13/2005US20050226894 Oral vaccination
10/13/2005US20050226885 Cytolysis of target cells by superantigen conjugates inducing T-cell activation
10/13/2005US20050226877 administration of a function blocking antibody which is capable of binding an epitope of VLA-1; arthritis
10/13/2005US20050226874 Point mutations; immunology
10/13/2005US20050226872 Use of cd25 binding molecules in the treatmnet of inflammatory diseases of the gastrointestinal tract
10/13/2005US20050226849 Compositions and methods of using capsid protein from Flaviviruses and Pestiviruses
10/13/2005US20050226813 Labelled somatostatin analogs backbone cyclized through metal complexation
10/13/2005DE60104282T2 Lösliche mutante ctla4 moleküle und deren verwendung Soluble CTLA4 mutant molecules and their use
10/13/2005CA2563024A1 Method for treating autoimmune diseases with antibodies
10/13/2005CA2561732A1 Antibody drug
10/13/2005CA2561530A1 Therapeutic or prophylactic agent for arthritis
10/13/2005CA2561401A1 Process for producing flavone c glycoside derivatives
10/13/2005CA2561394A1 Production and use of the methotrexate-albumin conjugate as an immunosuppressive agent in gvhd
10/13/2005CA2560818A1 Polymorphic forms of (1-{3-[3-(4-cyano-3-methoxy-phenyl)ureido]-phenyl}-ethyl)-carbamic acid-2-cyano-1-ethyl-ethyl ester
10/13/2005CA2560691A1 Tricyclic pyrazole kinase inhibitors
10/12/2005EP1584682A1 Regulation of bcl-2 gene expression
10/12/2005EP1584627A1 Dimerized peptide
10/12/2005EP1583744A2 Substituted benzylamine derivatives and methods of use
10/12/2005EP1583553A2 Therapeutic use of modulators of notch
10/12/2005EP1583533A1 Use of piperazine derivatives as ccr1 antagonists
10/12/2005EP1583529A2 Amino acid phenoxy ethers
10/12/2005EP1583526A1 Acylated 4-amidino- and 4-guanidinobenzylamines for the inhibition of plasma kallikrein
10/12/2005EP1583423A2 Intradermal cellular delivery using narrow gauge micro-cannula
10/12/2005EP1468012A4 Biomolecule transduction motif mph-1-btm and the use thereof
10/12/2005EP1448196B1 Benzothiazole derivatives as adenosine receptor ligands
10/12/2005EP1224173B1 Pyrazole derivatives as cannabinoid receptor antagonists
10/12/2005EP1216047B1 Combination of loteprednol and beta2-adrenoceptor agonists and its use by inhalation for the treatment of bronchial asthma
10/12/2005EP1163219B1 Substituted 1-oxo- and 1,3-dioxoisoindolines and their use in pharmaceutical compositions for reducing inflammatory cytokine levels
10/12/2005EP1140027B1 Dosage forms comprising porous particles
10/12/2005EP1060163B1 New piperazinyl-substituted pyridylalkane, alkene and alkine carboxamides
10/12/2005EP1049676B1 4- aryl(piperidin-4-yl)] aminobenzamides which bind to the delta-opioid receptor
10/12/2005EP1015459B9 Tetrazole-containing rapamycin analogs with shortened half-lives
10/12/2005EP0669979B1 C-c ckr-1, c-c chemokine receptor
10/12/2005CN1681926A Human antihuman MCP-1 antibody and antibody fragment thereof
10/12/2005CN1681918A Transplant acceptance inducing cells of monocytic origin and their preparation and use
10/12/2005CN1681917A Animal protein free media for cultivation of cells
10/12/2005CN1681823A Furoisoquinoline derivative and its application
10/12/2005CN1681818A Azaindole kinase inhibitors
10/12/2005CN1681815A Compositions useful as inhibitors of GSK-3
10/12/2005CN1681811A Azolidinone-vinyl fused-benzene derivatives
10/12/2005CN1681795A Pyrimidyl sulphone amide derivatives as chemokine receptor modulators
10/12/2005CN1681776A Amino alcohol derivative, addition salt thereof, and immunosuppressant
10/12/2005CN1681770A Amino-propanol derivatives
10/12/2005CN1681557A Methods for treating carbonic anhydrase mediated disorders
10/12/2005CN1681520A Dihydrate dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compostions thereof
10/12/2005CN1681508A Novel inhibitors of kinases
10/12/2005CN1681504A N-sulfonylpiperidines as metalloproteinase inhibitors (TACE)
10/12/2005CN1681503A Sulphonylpiperidine derivatives containing an aryl or heteroaryl group for use as matrix metalloproteinase inhibitors
10/12/2005CN1681500A Topical treatment of skin diseases
10/12/2005CN1680563A Amino alcohol derivatives
1 ... 531 532 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 ... 1172